BeStock  
Stocks › Biotechnology › OCS

Oculis OCS

US equityMarket cap rank #3648Biotechnology
$7.06 −$0.38 (-5.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.06 0.00%
Open$7.38
Prev close$7.44
Day range$6.98 – $7.43
Volume235.2K
Market cap$437.15M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.7x
CheapRich

Above its usual level · 64th percentile, 5-year average -5.6x

Price / book1.9x
CheapRich

Below its usual level · 33rd percentile, 5-year average 3.3x

#2977 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-16x-10x-4x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$10.54
Price vs. fair value-33.0%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.90 – 3.33 33% (cheaper than usual) #2977 of 5329 (1 = cheapest)
PE -4.75 -4.32 -5.57 64% (pricier than usual) –
PS – 894.16 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on OCS.

Sign in to join the discussion.

Scroll to Top